The global healthcare AI regulatory network led by HealthAI is set to gain a second European Union member: on 22 October 2026 Poland committed to join, becoming the second EU country after Portugal. India is already a member, and the agreement starts a one-year cooperation framework, though a HealthAI spokesperson said there is no fixed timeline for Poland’s formal accession.
Key takeaways on the global healthcare AI regulatory network
- Poland agreed on 22 October 2026 to join the HealthAI-led Global Regulatory Network, becoming the second EU member after Portugal.
- The agreement sets up a one-year cooperation framework; HealthAI says there is no fixed timeline for formal accession.
- Members get access to AI healthcare tools that regulators have reviewed, and a real-time warning system for harmful incidents involving AI.
- India is already a member, according to a wire-service report that lists Britain, Brazil, Singapore, the Philippines, Indonesia, Vietnam, Zambia and Peru among others.
- Joining a regulatory network is not the same as approving a specific AI product.
What the global healthcare AI regulatory network does
The network, run under the HealthAI banner, is a forum in which health regulators share work on AI used in medicine. According to the report, members can see AI healthcare tools that other regulators have already reviewed, which can save duplicated effort, and they can use a real-time system to report harmful incidents involving AI. The network’s own information is on the HealthAI website. We have not seen the text of the agreement with Poland.
The report links Poland’s move to new EU rules on AI and to rising concern about unpredictable AI behaviour. The EU’s framework is described on the European Commission website. How the two fit together in practice is not explained in the sources we reviewed.
Why Poland joining the global healthcare AI regulatory network matters
For a national regulator, a network offers two practical benefits. The first is information: when a tool has already been assessed elsewhere, a second regulator can learn from that work. The second is early warning: if an AI product causes harm in one country, others can learn about it quickly. Both are examples of what the report calls cross-border cooperation. They do not remove a regulator’s own responsibility to decide what is allowed in its market.
Timeline of Poland and the global healthcare AI regulatory network
- Earlier: Portugal becomes the first EU member of the network, according to the report.
- 22 October 2026: Poland commits to join and agrees a one-year cooperation framework.
- Within a year: Poland and HealthAI work under the framework, though no accession date is fixed.
- Later, date not set: formal accession, if it goes ahead.
The sequence above is our summary of the report. The dates for Portugal’s entry and for any accession decision are not given in the sources we reviewed.
What the one-year framework means for the global healthcare AI regulatory network
The report says the agreement establishes a one-year cooperation framework and that formal accession has no fixed date. In our reading, that means Poland and HealthAI will work together for a year, and a later decision will settle formal membership. This is our interpretation of the report, not a statement from HealthAI. Until accession, we cannot say which network services Poland will have full access to.
India and the global healthcare AI regulatory network
India’s membership gives the network a large member from a fast-growing market. Acumen Research and Consulting’s report AI in Healthcare Market Size, Share, Forecast Report 2026 to 2035 estimates the global AI in healthcare market at USD 41.84 billion in 2025, reaching USD 1,136.90 billion by 2035, a compound annual growth rate of 39.1% for 2026 to 2035. It says North America held about 43% of the market in 2025, Europe about 25%, and that Asia Pacific is expected to grow fastest, at a CAGR of 42.5%.
Those numbers are market estimates by Acumen and not data from HealthAI or from India’s regulators. They help explain why regulators in several regions want shared approaches: the more AI is used in care, the more likely it is that a safety issue in one country will matter in another. Related reading is in our Healthcare IT coverage.
General background: governing AI in health and the global healthcare AI regulatory network
Health AI covers many kinds of software, from tools that read images to systems that help triage patients. Regulators treat some as medical devices and others as lower-risk software. The World Health Organization has published guidance on the ethics and governance of AI for health, available on the WHO website. Networks such as HealthAI try to turn principles into shared working practice.
Our analysis: a governance step, not a product approval
In our assessment, the global healthcare AI regulatory network is best understood as plumbing for regulators: it connects them, lets them share reviews and warnings, and may reduce duplication. It does not certify any product on its own. A tool reviewed by one member is still subject to each country’s own rules.
What Poland gains in practice will depend on the final terms of accession. We make no claim about how quickly the network will grow or how effective it will be at preventing harm. Readers should also keep in mind that a larger membership list does not by itself prove that patients are safer; that depends on how often members report incidents and how quickly they act on them.
What is not disclosed about the global healthcare AI regulatory network deal
- The text of the Poland agreement and its fees, if any.
- The date for formal accession.
- Which AI tools have been reviewed and how many.
- How incident warnings are triaged and acted on.
- Whether other EU states are in talks.
Risks and caveats of the global healthcare AI regulatory network
This article relies on a wire-service report of the announcement and on the network’s public information. Membership lists can change. Acumen’s figures are third-party market estimates. This is news reporting and not legal, medical or investment advice.
What to watch next after the global healthcare AI regulatory network deal
- A date for Poland’s formal accession.
- Announcements of further EU members.
- Publication of incident-warning statistics.
- How the network interacts with EU AI rules.
FAQ
What is the global healthcare AI regulatory network?
A HealthAI-led network that lets health regulators share reviewed AI tools and warnings about harmful incidents.
Is Poland a member yet?
Not formally. It has committed to join under a one-year cooperation framework, and there is no fixed accession date.
Is India a member?
Yes, according to the report.
How we reported this: we relied on a wire-service report, the network’s public information and the Acumen Research and Consulting report cited above, and attributed every figure. Last updated 23 October 2026. This is news reporting and not advice.